Tailor-Made Genome

A method for rapidly replacing stop codons throughout the genetic code of E. coli paves the way for biomanufacturing designer proteins.

Written byTia Ghose
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

E. coliWIKIMEDIA COMMONS

One goal of synthetic biology is to design organisms that generate biomedically-, agriculturally-, or industrially-useful proteins, often incorporating novel amino acids into their sequences—a process that has thus far proven slow and difficult.

Now, researchers have demonstrated a first step toward a rapid, cheap, and automated way to allow the addition of a new amino acid to the cellular alphabet, successfully replacing a three-nucleotide stop codon throughout the E. coli genome, according to a study published today (July 14) in Science.

The new technique is “pretty impressive because it changes the types of things we can do with genomes,” said Adam Arkin, the director of the Synthetic Biology Institute at the University of California, Berkeley, who was not involved in the study. The findings are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies